102 Karen H. Rothenberg surrogate. Crispina and Anna both began hormonal therapy to mesh their ovulation cycles. Crispina had a number of eggs removed and fertilized with Mark's sperm, and three were transferred into Anna. Against the odds, one embryo implanted. For weeks, Anna received hormonal injections to maximize her chances of maintaining the pregnancy. She was hospitalized more than once for complications during the pregnancy. She was also advised to seek psychiatric help for emotional problems:~
The deal seemed to be working. Anna would receive $10,000 for her gestational services and for relinquishing the baby, the Calverts would have a genetic child, and the IVF program would contribute to another expansion of IVF for women who would otherwise not be able to benefit from such technology. But Anna, for whatever reason, changed her mind, and the deal began to fall apart. Seeking to invalidate the contract, she claimed among other things that she had bonded with the fetus and sought the court's protection of her future parental rights. Unwilling to recognize the possibility of three parents and Anna's role as the gestational mother (and probably doubting her claim that she had, in fact, bonded), the judge declared the contract valid and granted full and exclusive custody to the Calverts. 5 Anna Johnson filed an appeal on October 24, 1990. 6 
U.S. AND INTERNATIONAL DEVELOPMENTS IN POLICIES ON SURROGACY
Since the Baby M case made headlines a few years ago, policies on surrogacy continue to evolve around the world. 7 In the United States, legislation has been introduced in Congress and in thirty-nine states, as well as the District of Columbia, to deal with various aspects of commercial surrogacy. 8 To date, only thirteen states have passed laws dealing with surrogate parenting contracts and their legality. Eleven states have either declared commercial surrogacy illegal and/or made it impossible to enforce a contract as contrary to public policy. 9 A few of these states specifically include g~stational surrogacy within their definitional sections. 10 Arkansas allows for ·a birth certificate to be changed to recognize that the intended mother rather than the surrogate is the legal mother, but is vague about the parameters of the legality of surrogacy.
11 New Hampshire's recent statute permits, but with extensive regulation and pre-approval by the court, both forms of surrogacy. 12 No statute gives more rights to the surrogate with a genetic connection than to the gestational surrogate. 13 Bioethical task forces in both New Jersey and New York have also recommended that surrogacy not be allowed, particularly in the commercial setting, and that the surrogate be given the right to keep the child.
14 In fact, the New Jersey Task Force recommends that it be criminal for professionals to participate in commercial surrogacy. The prohibition can subject the professional to a charge of unprofessional conduct and prosecution. 15 Such participation in surrogacy might include screening of candidates and performing artificial insemination and embryo transfer with a gestational surrogate.
The most recent survey of international laws and policies clearly establishes that surrogacy contracts, especially if commercial, are illegal, unenforceable, contrary to public policy and/or void. 16 Furthermore, most laws establish that the birth mother is deemed the legal mother. 17 Of particular interest, Bulgaria declares that motherhood is determined by birth, whether or not conception is with another's genetic material. 18 Israeli regulations establish that a fertilized egg may be implanted only in the intended mother. 19 In Norway and Sweden, a fertilized egg may only be placed back into the woman from which the egg was removed. 20 In Spain, surrogacy with or without money is null and void, but if there is a contract for gestation, it declares that the mother who gave birth is still the mother. 21 The United Kingdom bans commercial surrogacy agencies from engaging women to act as su~TQgate mothers/ 2 and the German parliament just passed a law banning both surrogate motherhood and embryo transfer. 23 The Council of Europe has declared that "maternity should be determined by the fact of giving birth, rather than genetics (origin of the ova), firstly because of the relationship between the child and the woman giving birth to him and, secondly, because of the necessity of giving the child a clear legal situation at birth." 24 Furthermore, absent an exceptional case, surrogate motherhood should be banned and such contracts should be deemed null and void. 25 The council cautions that physicians should be prohibited from bringing together an infertile couple and a surrogate mother.
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Health-professional organizations both in the United States and abroad have also taken positions. The American Medical Association in December of 1988 incorporated its earlier report on surrogacy into the official opinions of its Council on Ethical and Judicial Affairs. Whether genetic or gestational, the opinion states that surrogacy "does not represent a satisfactory reproductive alternative for people who wish to become parents.'m This past June, the Ethics Committee of the American Fertility Society also reissued, with minor changes, its position recommending that surrogacy and gestational surrogacy be continued only as a "clinical experiment". 28 The Committee on Ethics of the American College of Obstetrics and Gynecology (ACOG) just issued its revised opinion in "Ethical Issues in Surrogate Motherhood." 29 The committee found that the surrogate who both carries the fetus and delivers the infant should be the sole source of consent for all questions regarding prenatal care and delivery, and that she should have a specified time after birth to decide whether or not to place the child for adoption with the commissioning couple. The opinion specifically addresses, in part, gestational surrogacy and recognizes that while the genetic link to the couple is important, it deems it "less weighty than the link between the surrogate mother and the fetus or infant that is created through gestation and birth. '' 30 Thus, the opinion makes no ethical distinction between what it describes as "the usual pattern of surrogate parenting and surrogate gestational motherhood. '' 31 The ACOG committee further states that the physician, when approached, should assure all disclosure of medical and ethical risk and that the provider may justifiably decline participating in a surrogacy arrangement. If the physician does agree to participate, strict ethical guidelines should be followed. Of particular interest is that the surrogate and the commissioning couple should be regarded as distinct parties and should be separately represented, both medically and legally. 32 In August 1990, the Working Party on Human Infertility Services of the British Medical Association (BMA) adopted extensive ethical guidelines on surrogacyY These guidelines supersede a 1987 ruling that doctors should not take part in surrogacy arrangements until the BMA had agreed upon ethical controls. 34 The BMA guidelines warn physicians that surrogacy arrangements are unenforceable in law and that neither of the parties can be prevented from breach. 35 The guidelines provide that surrogacy be a last resort, that ' doctors consider as surrogates only those women who have a partner and already have one child. Physicians should also warn the commissioning couple, the surrogate, and her partner of all risks (which the BMA outlines in great detail), including the possibility that the surrogate may refuse to relinquish the child and that the commissioning couple may refuse to accept a child born with any defects. 36 The Working Party makes no ethical or legal distinction between "partial" (genetic) and "full" (gestational) surrogacy. In fact, they note that "whatever the genetic origins of a child, and regardless of the wishes of the participants, the law regards the child as belonging to the mother who delivered it." 37 
GESTATIONAL SURROGACY: ETHICAL AND LEGAL PROBLEMS
The American College of Obstetrics and Gynecology and the British Medical Association both have accepted the political reality that infertility specialists fear restrictions on their practice. In fact, some IVF programs are part of the created demand for legalized surrogacy. Surrogacy in this medical context reduces gestation to a technological tool. This is understandable, considering the increasing expectation of the couple believing that with enough technology anyone can have a baby.
At the same time this medicalization reduces the role played by the gestational mother in the creation of life. The surrogate is deemed to be making a healthy adjustment if she remains unconnected -the most unnatural of feelings. This is too great a risk for health care professionals to contribute to reducing women to extensions of a medical process.
Furthermore, as an international matter, gestational surrogacy has the potential to exploit poor women from Third World countries, perhaps raising the false hope of immigration to the United States. Rich white couples, in turn, desperate for a genetic connection, can use poor women to achieve the result. Health care professionals cannot condone using women in this way.
I would strongly urge that health professionals resist any support of the use of a gestational surrogate. Obviously we all want to satisfy the infertile couple with the option of IVF. But we have to set limits when another woman, also being treated as a unit by the IVF program, is involved. We are pitting mothers against each other, and the health care provider is potentially in the middle of the conflict. The right law, the right contract, and the right counseling will not be able to correct the problems with gestational surrogacy.
I do not make this argument in defense of Anna Johnson, or in reaction to that case. Although I am surprised that we have not seen more cases to date, they will come, and the health care provider will be in a no-win position. 38 Let me highlight the specific issues that gestational surrogacy poses for the health care professional throughout the process.
Screening
PropOnents of surrogacy believe that with enough screening by qualified professionals, surrogacy can be a success. The recent New Hampshire statute, 39 in fact, provides for professional screening of both the couple and the surrogate to assure a court in a pre-approval process that the contract will work. Yet what are we screening for?
For example, how does a psychologist assess whether a gestational surrogate is a good risk? 40 If she is less willing to want to bond because there is no genetic connection, will she remain this way throughout the gestational process? And what if she continues to feel removed, because there is no genetic connection? Will this influence her prenatal behavior to make her a bad risk and a noncompliant patient? The data does not exist to develop the perfect profile of the surrogate and the commissioning couple who can cope with IVF and embryo transfer. What are the measures of motivation, self-esteem, family support, and experience in coping with childbearing loss? What relationship will the genetic and the gestational mother have to each other? What perception does the surrogate have of the father and the future of a unit relationship? Certainly we do not have experience with genetic parents dealing with loss to the gestational mother.
We do have some experience that supports the possibility of motivation to deny or omit feelings and relevant medical information. And there may be unconscious motivation not to hear or appreciate all the risks when the motivation is so strong for both the couple and the IVF program to achieve a pregnancy, and for the surrogate to be successful and to be paid.
In the first medical malpractice case filed that involved the treatment of a surrogate, Mounce v. Hanson, 41 the surrogate admitted to the physician who took her medical history that she had had two prior miscarriages and no live births. She was not screened out. Perhaps more important, she did not state that she had had a history of heart trouble. She was desperate to serve as a surrogate, perhaps as a way to deal with her prior losses, and to make some money. In her eighth month of pregnancy, she died of heart failure following a number of warning signals, and the baby died too. The sperm donor never came forward, but her family has sued Genesearch, the surrogacy program, the physician who screened her and provided her prenatal care, and the consulting cardiologist. 42 The Calverts claimed that Anna Johnson also failed to provide important medical information, in not revealing her two miscarriages and two stillbirths. 43 Clearly, she was not an ideal candidate, either medically or psychologically, for surrogacy. When money is involved, and when we all want something bad enough, screening may be of limited use without all the facts. And even if we think we have all the facts, we have to decide which facts are the ones that matter.
Thus, in spite of the call for screening to assure that the arrangement has the Good Housekeeping Seal of Approval, the process is flawed. First of all, we have no consensus on what we are screening for. Medically, what are the . -:-standards for an acceptable surrogate? The existence of a uterus and a willing carrier are not enough. Rather, I would argue that at the present time an infertile couple is not a candidate for IVF if the woman is not able to be the birth mother. As noted earlier, Norway, Sweden and Israel require that IVF be allowed only if the woman is implanted with her own genetic material. 44 Secondly, we do not know what the acceptable psychological profile is for a low risk couple and surrogate. And finally, professionals are not qualified to determine what information is meaningful. The ethical and legal, not to mention medical and psychological, risks are not clear, and by definition, they may never be.
Informed Consent
Assuming that both the couple and the surrogate pass the screening requirements, an elaborate informed consent process is to follow. ACOG, for example, recommends that the medical and the ethical risks be carefully spelled out to the couple and the surrogate. 45 The New Hampshire statute also requires an extensive evaluation, counseling, and an informed consent process. 46 But are health care providers qualified to do the job? And do they have enough information to make the process meaningful? How does a gestational surrogate consent knowingly to relinquishment of a future child? She may have experienced a birth, but is it easier or harder to relinquish if you have no genetic connection? Is the lack of a genetic connection relevant at all? Obviously, genetics matter to the couple, who may feel more strongly about losing their wholly genetic child.
In fact, how does a provider describe the ethical and legal risks? Fewer than a quarter of the states have laws that either hold surrogacy contracts unenforceable or heavily regulate them. 47 Under traditional family law, rather than contract law, the birth mother is the mother. Yet, in Johnson v. Calven the lower court in California found that genetics is all that matters, and the gestational mother has no rights. 48 
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Clearly, informed consent based on legal risks is risky at best. There are no guarantees. Nor are there any guarantees with respect to psychological risk for the couple, the surrogate, or the surrogate's family. Medically, there are unknown long-term risks associated with fertility drugs, IVF procedures, risk to the child, and risks to the gestational surrogate from multiple gestation. Obviously, the medical risks are more significant for the gestational surrogate than for the surrogate who is artificially inseminated and usually carries just a single fetus to term. Again, it is one thing to risk your own body. It is quite another to achieve "voluntary" consent to experiment with another woman's body for the couple's benefit.
Conflict of Interest and the Embryo Transfer
Assu~ing some form of informed consent is attempted, there still remain problems with the conflict of interest inherent in an IVF program promoting embryo transfer with a gestational surrogate. The couple and their surrogate are treated like a unit with the same interest -the achievement of a successful pregnancy. The client, however, is not the surrogate but the paying couple. The surrogate is needed to allow the provider to extend the potential of IVF use into a "uterine carrier." The surrogate is a means to an end. How can the physician maintain a confidential relationship with two women who are both potential mothers of the same baby or babies?
Furthermore, the medical risks are significant for both the genetic and gestational mother. First, their ovulatory cycles must coincide. Drugs are necessary to manipulate their cycles. Fertility drugs also may help to stimulate the production of eggs by the genetic mother-to-be so that a number of eggs can be retrieved. The husband's sperm is then combined with the eggs, and any resulting embryos are transferred into the gestational surrogate. The surrogate continues to receive hormonal injections for a number of weeks to maximize the chances of a successful implantation and pregnancy. The IVF program has a responsibility for the well-being of all members of this unit. This is a risky business. Once the IVF process is finished, the IVF program may think its job is over. A pregnancy (or pregnancies) has been achieved, yet there is potential for future maternal morbidity and mortality for both mothers-to-be. It is one thing to assume these risks when the genetic mother is also to be the host uterus. It is different, however, when there is potential for conflict within the unit. In fact, all the parties cannot be treated as a unit. They are individual patients, with individual needs, and the provider must avoid any appearance of conflict of interest. Yet by definition, IVF and embryo transfer with a gestational surrogate is a case of potential conflict of interest. The ACOG committee opinion states that conflict of interest must be avoided by the use of separate medical providers for infertility and care to the surrogate. 49 For the process to work, will we tolerate inherent conflict which clearly favors the interests of the consumers of the IVF technology over the surra-gate? Does the IVF provider have, in faCt, a physician-patient relationship with the surrogate, or does the provider take the surrogate as a mere extension of the procedure? How much responsibility will the IVF program take for screening a surrogate? If the surrogate is good enough for the couple, is the surrogate good enough for the IVR provider? It is the responsibility of the provider to warn the surrogate of all risks, but is this not in conflict with the couple's goals and interests?
The ACOG committee opinion provides that the surrogate is the source of all medical decisions with respect to the pregnancy. 5° For in fact, once the transfer is complete, all biological connections are made by the gestational mother-to-be. She is more than a uterine container. 51 She provides all the nutrients and bodily functions necessary to make this embryo grow into a fetus and then a baby. Clearly the interest of all is in her physical and emotional well-being. And any psychological counseling -~ecessary during pregnancy must be directed to doing what is best for the pregnant woman.
Multiple Embryo Transfer
It is common IVF practice to transfer at least three fertilized embryos. Some IVF programs transfer up to six. 5 2 Obviously, this practice attempts to maximize the chances of achieving a pregnancy. However, twins, triplets, and maybe more are to be expected. A World Health Organization study on IVF found that with the potential for multiple births, maternal morbidity and mortality, as well as infant morbidity and mortality, significantly increase. 5 3 If the genetic mother chooses to take this risk with her body, it is one thing. But health care professionals should not impose such risks on the gestational surrogate whose body is being used for the couple's benefit.
Multiple gestation and its risks raise problems for gestational surrogacy that were not considered with genetic surrogacy, in which single gestation is the norm. The risks to all parties, including the liability of the IVF physician, increase. It is more likely that the gestational surrogate will become a high risk pregnancy, will require a cesarean section delivery, will have more complications and more monitoring, and will be unable to continue working throughout the pregnancy. And how do we then compensate fairly for this additional burden of gestational service and for relinquishing more than one baby?
Obviously the potential conflict of interest for the IVF provider is raised again. Just how many embryos should be transferred? On the one hand, selective termination of the "extra" fetuses might be the answer for the genetic couple. 54 But what about the surrogate's view? Perhaps she will not want to abort and will risk carrying three or four to term. Of course, this decision also raises the risk to her and the fetuses.
Ultimately, if the gestational surrogate is the decisionmaker for medical care, she and not the genetic couple must decide what is best for her health and the health of the fetuses, including selective termination of pregnancy. This is not to say that the couple and provider will not exert pressure on her.
Prenatal Diagnosis and Genetic Testing
A standard surrogate contract will require the surrogate to undergo genetic testing, including amniocentesis, to establish whether or not there are any genetic or chromosomal abnormalities. Yet is this not a strange requirement for the gestational surrogate? The gestational surrogate is not the genetic carrier of the problems being screened for. Obviously genetic counseling has no function for her. Such counseling is relevant to the genetic couple, but it is the surrogate who is subjecting herself to the testing. Once again she would have the right not to abort a defective fetus, but if the couple then rejects the fetus, who gets the child? Unless the surrogate chooses to keep the child with ne genetic link to her, the child may become a ward of the state. What if she does choose to abort the fetus, because she does not want to carry a "defective" pregnancy, and the couple still wants the pregnancy to continue? It is the couple's genetic material, and they are willing to accept the result. Yet, if they desire the surrogate to have genetic testing, it would seem that the couple would have to accept her decision to abort. Regardless of the result, the use of genetic testing with gestational surrogates raises unique ethical and legal challenges for the provider.
Control of Behavioral Lifestyle and Work Environment
In addition to genetic testing, surrogate contracts often require that surrogates do not drink, smoke, or take illicit drugs. Obviously enforcement of such provisions is problematic. Such provisions require that the physician take on the role of spy rather than fiduciary toward the patient. In fact, the ACOG committee opinion clearly provides that the confidential relationship remains with the surrogate.
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However, with gestational surrogacy it would seem that the couple, and perhaps the physician, will feel more a hold on the gestational surrogate. Since she has no genetic connection to the pregnancy, they may fear she will be less concerned with taking care of herself and the fetus. There have been cases in which health care providers have gone to court to try to force certain treatments or cesarean section deliveries. 56 A couple, with the support of the provider, having invested so much time, emotional energy, and money in achieving a pregnancy, may feel they have no recourse other than to go to court to protect their genetic material from the negative behaviors of the surrogate. The couple might try to argue that their intention to rear the child, as well as the force of the contract, gives them legal standing to seek an injunction to get the surrogate to undergo a medical procedure or to stop smoking, drinking, or taking drugs during the pregnancy. It is not clear whether the court would be more or less concerned about the autonomy of the pregnant II 0 Karen H. Rothenberg woman to control her own body when she has no intention to rear the child and to accept the consequences of her actions. One also wonders what the psychological impact of not carrying a genetic fetus has on the acts and behavior of the surrogate, as well as on the health of the uterine environment. If in fact it is easier to separate, is it easier to ignore other concerns for the fetus?
Furthermore, what will be the implications for employment of the surrogate? Is gestating her only job? Does she have the right to continue any other employment? If she works in a lead factory, must she be forced to be transferred or fired? 57 What if she is having twins and is told "to get off her feet?" If she stops working, will the couple pay her lost earnings? Will she be barred from disability payments if her pregnancy resulted from an embryo transfer for hire? What role will the provider play in helping her to obtain disability ,ceverage? With the increase in medical risks come increasing economic risks.
.
'

Birth Defects and Causation
Unfortunately, no one can guarantee the birth of a healthy child. With gestational surrogacy, it may be more difficult to determine the cause of a problem at birth. Was it a genetic problem? Was it the surrogate's work environment? Was it the one drink? Was it caused by a sexually transmitted disease that she caught during relations with her husband? Gestational surrogacy takes genetics out of the picture, but it may be difficult to pin the problem on a particular cause. In the end, will the couple and/or the surrogate, if she retains custody, look to the physician for a financial solution through a liability claim? With so much that cannot be controlled in the birth process, and with such high expectations and expenses generated from IVF and embryo transfer, a liability threat from both the surrogate and commissioning couple should not be minimized.
CONCLUSION
State courts and legislatures, health-professional organizations, and policymakers throughout the world are struggling to develop laws and guidelines to address the complex questions raised by the expansion of new reproductive technologies. Clearly, infertility specialists are sincerely devoted to trying to help couples have their own babies. But health care professionals must resist the temptation to expand the use of IVF and embryo transfer with gestational surrogacy. The medical, ethical, and legal risks of using another woman to serve the interests of the infertile couple cannot be minimized. Gestational surrogacy is not a cure for infertility, but rather a course to be avoided.
